Search

everythinglearnresearchcommunity

for

Search:↓

A man's scalp hair loss was due to a combined melanocytic nevus and alopecia areata, suggesting a possible link between the two conditions.

Targeting and modifying the stem cell niche can improve regenerative therapies.

New methods like nanoparticles and microneedles show promise for better skin drug delivery, especially for hair disorders.

Targeting Vδ1+T-cells may help treat alopecia areata.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Tiny particles from brain cells help hair grow by targeting a specific hair growth pathway.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Type I interferons play a key role in the development of various skin diseases.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Laser hair removal is the most requested cosmetic procedure and has become a scientifically-based treatment suitable for all skin types.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Substance from human umbilical cord blood cells promotes hair growth.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Leflunomide is more likely to help treat alopecia areata than cause it.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.